Working… Menu

AGEN2034 & AGEN1884 in Patients With Recurrent, Inoperable Angiosarcoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04607200
Recruitment Status : Recruiting
First Posted : October 29, 2020
Last Update Posted : February 1, 2021
Information provided by (Responsible Party):
Agenus Inc.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2021
Estimated Study Completion Date : December 1, 2023